Recent studies have shown that enhancement of T cell activation through PD-1 blockade is beneficial for chronic viral infections with HIV, HCV, HBV and HTLV (Kozako et al., 2009, Porichis and Kaufmann, 2012, Watanabe et al., 2010). The gene discussed is PDCD1; the disease is viral infectious disease.